PMC:7152526 / 13004-13182
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 317 | 152-160 | Disease | denotes | infected | MESH:D007239 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T88 | 161-165 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T138 | 161-165 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T102 | 0-178 | Sentence | denotes | Besides, in vivo studies showed that the effects of neutralizing antibodies were not only limited to viral clearance, but also included acceleration of infected cell clearance.15 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T214 | 65-75 | GO:0042571 | denotes | antibodies |
| T215 | 101-106 | NCBITaxon:10239 | denotes | viral |
| T216 | 161-175 | GO:0043277 | denotes | cell clearance |
| T43247 | 65-75 | GO:0042571 | denotes | antibodies |
| T64800 | 101-106 | NCBITaxon:10239 | denotes | viral |
| T6672 | 161-175 | GO:0043277 | denotes | cell clearance |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32281317-27199430-61647294 | 176-178 | 27199430 | denotes | 15 |